In addition to increasing PHGDH, an increase of nicotinamide phosphoribosyltransferase (NAMPT), a rate-limiting enzyme of NAD+ salvage pathway, was also shown in ER-negative breast cancer lines and patient-derived breast tumors [123]. This evidence concerns the gene NAMPT and breast neoplasm.